Platelets delivering the immunotherapeutic antibody anti-PD-L1 to the site of surgically removed tumours reduce cancer recurrence and metastatic spread in mice.
This is a preview of subscription content, log in via an institution to check access.
References
Leach, D. R., Krummel, M. F. & Allison, J. P. Science 271, 1734–1736 (1996).
Freeman, G. J. et al. J. Exp. Med. 192, 1027–1034 (2000).
Boutros, C. et al. Nat. Rev. Clin. Oncol. 13, 473–486 (2016).
Schadendorf, D. et al. J. Clin. Oncol. 33, 1889–1894 (2015).
Webster, R. M. Nat. Rev. Drug. Discov. 13, 883–884 (2014).
Forde, P. et al. Ann. Oncol. 27, LBA41_PR (2016).
Eggermont, A. M. et al. N. Engl. J. Med. 375, 1845–1855 (2016).
Meier, J. D., Oliver, D. A. & Varvares, M. A. Head Neck 27, 952–958 (2005).
Wang, C. et al. Nat. Biomed. Eng. 1, 0011 (2017).
http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761034s000lbl.pdf
Franco, A. T., Corken, A. & Ware, J. Blood 126, 582–588 (2015).
Sharma, P. & Allison, J. P. Science 348, 56–61 (2015).
Weber, J. S. et al. Lancet Oncol. 16, 375–384 (2015).
Shi, J., Kantoff, P. W., Wooster, R. & Farokhzad, O. C. Nat. Rev. Cancer 17, 20–37 (2017).
Hu, C.-M. J. et al. Nature 526, 118–121 (2015).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Mahmoudi, M., Farokhzad, O. Cancer immunotherapy: Wound-bound checkpoint blockade. Nat Biomed Eng 1, 0031 (2017). https://doi.org/10.1038/s41551-017-0031
Published:
DOI: https://doi.org/10.1038/s41551-017-0031
- Springer Nature Limited
This article is cited by
-
Quantification of biomarker functionality predicts patient outcomes
British Journal of Cancer (2021)
-
Targeting PVR (CD155) and its receptors in anti-tumor therapy
Cellular & Molecular Immunology (2019)
-
T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword
Nature Reviews Cardiology (2019)
-
Radiopharmacology and molecular imaging of PD-L1 expression in cancer
Clinical and Translational Imaging (2018)